EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan
Abstract
Authors
S Ozeki K Moriwaki K Morimoto K Shimozuma
S Ozeki K Moriwaki K Morimoto K Shimozuma
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now